115 related articles for article (PubMed ID: 18174012)
21. Lower Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Promotes the Proliferation and Migration of Endometrial Carcinoma.
Xia X; Wang J; Liu Y; Yue M
Med Sci Monit; 2017 Feb; 23():966-974. PubMed ID: 28225751
[TBL] [Abstract][Full Text] [Related]
22. Fertility-preservation in endometrial cancer: is it safe? Review of the literature.
Carneiro MM; Lamaita RM; Ferreira MC; Silva-Filho AL
JBRA Assist Reprod; 2016 Dec; 20(4):232-239. PubMed ID: 28050959
[TBL] [Abstract][Full Text] [Related]
23. Utility of Pelvic MRI and Tumor Markers HE4 and CA125 to Predict Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer.
Zamani N; Modares Gilani M; Zamani F; Zamani MH
J Family Reprod Health; 2015 Nov; 9(4):177-83. PubMed ID: 27047564
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of increased ZIC1 expression in human endometrial cancer.
Gu X; Liu Q; Yang N; Shen JF; Zhang XG; Cao F; Ding HZ
J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):898-903. PubMed ID: 26670443
[TBL] [Abstract][Full Text] [Related]
25. EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.
Liu DT
Tumour Biol; 2015 Jul; 36(7):4883-8. PubMed ID: 25967458
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in cyclooxygenase-2 gene in endometrial cancer patients.
Torricelli F; Mandato VD; Farnetti E; Abrate M; Casali B; Ciarlini G; Pirillo D; Gelli MC; Costagliola L; Nicoli D; Palomba S; La Sala GB
Tumour Biol; 2015 Sep; 36(10):7423-30. PubMed ID: 25900875
[TBL] [Abstract][Full Text] [Related]
27. Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
Kitajima K; Suenaga Y; Ueno Y; Maeda T; Ebina Y; Yamada H; Okunaga T; Kubo K; Sofue K; Kanda T; Tamaki Y; Sugimura K
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1268-75. PubMed ID: 25833351
[TBL] [Abstract][Full Text] [Related]
28. ZEB1 expression in endometrial biopsy predicts lymph node metastases in patient with endometrial cancer.
Feng G; Wang X; Cao X; Shen L; Zhu J
Dis Markers; 2014; 2014():680361. PubMed ID: 25544793
[TBL] [Abstract][Full Text] [Related]
29. Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.
Tolcher MC; Swisher EM; Medeiros F; Lima JF; Hilderbrand JL; Donovan JL; Garcia RL; Cliby WA; Dowdy SC
Int J Gynecol Pathol; 2015 Jan; 34(1):57-64. PubMed ID: 25473754
[TBL] [Abstract][Full Text] [Related]
30. Surgical and systemic management of endometrial cancer: an international survey.
Fotopoulou C; Kraetschell R; Dowdy S; Fujiwara K; Yaegashi N; Larusso D; Casado A; Mahner S; Herzog TJ; Kehoe S; Vergote I; Miller DS; Marth C; Fujii S; Sehouli J
Arch Gynecol Obstet; 2015 Apr; 291(4):897-905. PubMed ID: 25315381
[TBL] [Abstract][Full Text] [Related]
31. Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.
Zhou XM; Zhang H; Han X
Tumour Biol; 2014 Oct; 35(10):9523-30. PubMed ID: 25168372
[TBL] [Abstract][Full Text] [Related]
32. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
[TBL] [Abstract][Full Text] [Related]
33. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S
Dis Markers; 2014; 2014():298795. PubMed ID: 24692842
[TBL] [Abstract][Full Text] [Related]
34. Stromal derived factor-1 (SDF-1) and its receptors CXCR4 and CXCR7 in endometrial cancer patients.
Walentowicz-Sadlecka M; Sadlecki P; Bodnar M; Marszalek A; Walentowicz P; Sokup A; Wilińska-Jankowska A; Grabiec M
PLoS One; 2014; 9(1):e84629. PubMed ID: 24416254
[TBL] [Abstract][Full Text] [Related]
35. Endometrial Assessment: When is it Necessary?
Pessoa JN; Freitas AC; Guimaraes RA; Lima J; Dos Reis HL; Filho AC
J Clin Med Res; 2014 Feb; 6(1):21-5. PubMed ID: 24400027
[TBL] [Abstract][Full Text] [Related]
36. The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses.
Hromadnikova I; Kotlabova K; Pirkova P; Libalova P; Vernerova Z; Svoboda B; Kucera E
DNA Cell Biol; 2014 Jan; 33(1):40-8. PubMed ID: 24283364
[TBL] [Abstract][Full Text] [Related]
37. Studies on the role of osteopontin-1 in endometrial cancer cell lines.
Hahne JC; Meyer SR; Kranke P; Dietl J; Guckenberger M; Polat B; Hönig A
Strahlenther Onkol; 2013 Dec; 189(12):1040-8. PubMed ID: 24126938
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated fibroblasts promote proliferation of endometrial cancer cells.
Subramaniam KS; Tham ST; Mohamed Z; Woo YL; Mat Adenan NA; Chung I
PLoS One; 2013; 8(7):e68923. PubMed ID: 23922669
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome.
Huang M; Djordjevic B; Yates MS; Urbauer D; Sun C; Burzawa J; Daniels M; Westin SN; Broaddus R; Lu K
Cancer; 2013 Aug; 119(16):3027-33. PubMed ID: 23760948
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.
Kitajima K; Kita M; Suzuki K; Senda M; Nakamoto Y; Sugimura K
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):840-5. PubMed ID: 22349717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
